{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T21:20:18Z","timestamp":1787606418817,"version":"build-2736575974"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography A"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.chroma.2026.467244","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T23:41:49Z","timestamp":1783467709000},"page":"467244","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Detection of ionisable lipids in equine plasma by supported liquid extraction and liquid chromatography-high-resolution tandem mass spectrometry for doping control of mRNA agents"],"prefix":"10.1016","volume":"1785","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-0433-0845","authenticated-orcid":false,"given":"Bruce Pui-Nam","family":"Yuen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7136-4712","authenticated-orcid":false,"given":"Kin-Sing","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2471-1790","authenticated-orcid":false,"given":"Hiu Wing","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmie Ngai-Man","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wing-Tak","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chroma.2026.467244_bib0001","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1016\/j.ymthe.2025.03.034","article-title":"Clinical development of therapeutic mRNA applications","volume":"33","author":"\u017bak","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.chroma.2026.467244_bib0002","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12929-024-01080-z","article-title":"Current landscape of mRNA technologies and delivery systems for new modality therapeutics","volume":"31","author":"Lu","year":"2024","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.chroma.2026.467244_bib0003","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ymthe.2023.10.024","article-title":"mRNA vaccines and their delivery strategies: a journey from infectious diseases to cancer","volume":"32","author":"Malla","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.chroma.2026.467244_bib0004","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.3390\/life12081254","article-title":"The delivery of mRNA vaccines for therapeutics","volume":"12","author":"Nitika","year":"2022","journal-title":"Life"},{"key":"10.1016\/j.chroma.2026.467244_bib0005","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/s41573-021-00283-5","article-title":"mRNA vaccines for infectious diseases: principles, delivery and clinical translation","volume":"20","author":"Chaudhary","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.chroma.2026.467244_bib0006","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3390\/vaccines9010065","article-title":"Nanomaterial delivery systems for mRNA vaccines","volume":"9","author":"Buschmann","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.chroma.2026.467244_bib0007","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/j.ymthe.2018.03.010","article-title":"A novel amino lipid series for mRNA delivery: improved endosomal escape and sustained pharmacology and safety in non-human primates","volume":"26","author":"Sabnis","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.chroma.2026.467244_bib0008","doi-asserted-by":"crossref","first-page":"8529","DOI":"10.1002\/anie.201203263","article-title":"Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivo","volume":"51","author":"Jayaraman","year":"2012","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.chroma.2026.467244_bib0009","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jconrel.2005.06.014","article-title":"Cationic lipid saturation influences intracellular delivery of encapsulated nucleic acids","volume":"107","author":"Heyes","year":"2005","journal-title":"J. Control. Rel."},{"key":"10.1016\/j.chroma.2026.467244_bib0010","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0005-2736(00)00343-6","article-title":"Efficient encapsulation of antisense oligonucleotides in lipid vesicles using ionizable aminolipids: formation of novel small multilamellar vesicle structures","volume":"1510","author":"Semple","year":"2001","journal-title":"Biochim. Biophys. Acta BBA Biomembr."},{"key":"10.1016\/j.chroma.2026.467244_bib0011","doi-asserted-by":"crossref","first-page":"35835","DOI":"10.1021\/acsami.0c08268","article-title":"Surface-functionalized PEGylated nanoparticles deliver messenger RNA to pulmonary immune cells","volume":"12","author":"Ke","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.chroma.2026.467244_bib0012","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1021\/acscentsci.9b00843","article-title":"Fine-tuning of hydrophobicity in amphiphilic polyaspartamide derivatives for rapid and transient expression of messenger RNA directed toward genome engineering in brain","volume":"5","author":"Kim","year":"2019","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.chroma.2026.467244_bib0013","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ejpb.2019.05.014","article-title":"Peptide-mediated delivery of therapeutic mRNA in ovarian cancer","volume":"141","author":"Van Den Brand","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.chroma.2026.467244_bib0014","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jconrel.2014.06.048","article-title":"Development and characterization of self-assembling nanoparticles using a bio-inspired amphipathic peptide for gene delivery","volume":"189","author":"McCarthy","year":"2014","journal-title":"J. Control. Rel."},{"key":"10.1016\/j.chroma.2026.467244_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2024.115446","article-title":"Breaking the final barrier: evolution of cationic and ionizable lipid structure in lipid nanoparticles to escape the endosome","volume":"214","author":"Mrksich","year":"2024","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.chroma.2026.467244_bib0016","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.addr.2020.12.011","article-title":"COVID-19 vaccines: the status and perspectives in delivery points of view","volume":"170","author":"Chung","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.chroma.2026.467244_bib0017","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1177\/2051013613508729","article-title":"A development that may evolve into a revolution in medicine: mRNA as the basis for novel, nucleotide-based vaccines and drugs","volume":"2","author":"Kallen","year":"2014","journal-title":"Ther. Adv. Vaccines"},{"key":"10.1016\/j.chroma.2026.467244_bib0018","unstructured":"World Anti-Doping Agency (WADA), Section M3 of the Prohibited list. https:\/\/www.wada-ama.org\/sites\/default\/files\/2025-09\/2026list_en_final_clean_september_2025.pdf (accessed March 20, 2026)."},{"key":"10.1016\/j.chroma.2026.467244_bib0019","unstructured":"International Federation of Horseracing Authorities (IFHA), Article 6B of the international agreement on breeding, racing and wagering and appendixes. https:\/\/www.ifhaonline.org\/default.asp?section=IABRW&area=2#article6B (accessed March 25, 2026)."},{"key":"10.1016\/j.chroma.2026.467244_bib0020","unstructured":"F\u00e9d\u00e9ration \u00c9questre Internationale (FEI), Article 1004 (1) of the FEI veterinary regulations 2026. https:\/\/inside.fei.org\/content\/fei-veterinary-regulations-2026 (accessed March 20, 2026)."},{"key":"10.1016\/j.chroma.2026.467244_bib0021","doi-asserted-by":"crossref","first-page":"4191","DOI":"10.1007\/s00216-026-06513-2","article-title":"Direct LC-HRMS\/MS characterisation and RT-qPCR detection for potential mRNA-based doping agent","volume":"418","author":"Yuen","year":"2026","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.chroma.2026.467244_bib0022","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1080\/15257770.2025.2451377","article-title":"Innovations in RNA therapeutics: a review of recent advances and emerging technologies","volume":"44","author":"Dweh","year":"2025","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"10.1016\/j.chroma.2026.467244_bib0023","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1021\/acs.analchem.5c05862","article-title":"Direct single-molecule detection of mRNA-LNP drugs in blood","volume":"98","author":"Furukawa","year":"2026","journal-title":"Anal. Chem."},{"key":"10.1016\/j.chroma.2026.467244_bib0024","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10556","article-title":"Novel piperazine-based ionizable lipid nanoparticles allow the repeated dose of mRNA to fibrotic lungs with improved potency and safety","volume":"8","author":"Kim","year":"2023","journal-title":"Bioeng. Transl. Med."},{"key":"10.1016\/j.chroma.2026.467244_bib0025","doi-asserted-by":"crossref","first-page":"3955","DOI":"10.1073\/pnas.1322937111","article-title":"Lipopeptide nanoparticles for potent and selective siRNA delivery in rodents and nonhuman primates","volume":"111","author":"Dong","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.chroma.2026.467244_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121570","article-title":"An imidazole modified lipid confers enhanced mRNA-LNP stability and strong immunization properties in mice and non-human primates","volume":"286","author":"Ripoll","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.chroma.2026.467244_bib0027","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1038\/s41467-020-16248-y","article-title":"Synergistic lipid compositions for albumin receptor mediated delivery of mRNA to the liver","volume":"11","author":"Miao","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.chroma.2026.467244_bib0028","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3390\/pharmaceutics13040544","article-title":"Delivery of oligonucleotides using a self-degradable lipid-like material","volume":"13","author":"Tanaka","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.chroma.2026.467244_bib0029","unstructured":"G. Isaac, N. Ranbaduge, B.A. Alden, C. Quinn, W. Chen, R.S. Plumb, Rapid analysis of lipid nanoparticle components using BioAccord LC-MS system. https:\/\/www.waters.com\/nextgen\/us\/en\/library\/application-notes\/2021\/rapid-analysis-of-lipid-nanoparticle-components-using-bioaccord-lc-ms-system.html (accessed December 13, 2025)."},{"key":"10.1016\/j.chroma.2026.467244_bib0030","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.chroma.2026.467244_bib0031","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.chroma.2026.467244_bib0032","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1021\/acs.accounts.1c00544","article-title":"Chemistry of lipid nanoparticles for RNA delivery","volume":"55","author":"Eygeris","year":"2022","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.chroma.2026.467244_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.114056","article-title":"Influence of ionisable lipid and sterol variations on lipid nanoparticle properties and performance","volume":"386","author":"McMillan","year":"2025","journal-title":"J. Control. Rel."},{"key":"10.1016\/j.chroma.2026.467244_bib0034","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jconrel.2024.11.010","article-title":"Exploring the impact of commonly used ionizable and pegylated lipids on mRNA-LNPs: a combined in vitro and preclinical perspective","volume":"377","author":"Binici","year":"2025","journal-title":"J. Control. Rel."},{"key":"10.1016\/j.chroma.2026.467244_bib0035","doi-asserted-by":"crossref","DOI":"10.1002\/ange.202304977","article-title":"Real-time pH-dependent self-assembly of ionisable lipids from COVID-19 vaccines and in situ nucleic acid complexation","volume":"135","author":"Yu","year":"2023","journal-title":"Angew. Chem."},{"key":"10.1016\/j.chroma.2026.467244_bib0036","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.copbio.2021.09.016","article-title":"Principles for designing an optimal mRNA lipid nanoparticle vaccine","volume":"73","author":"Kon","year":"2022","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.chroma.2026.467244_bib0037","doi-asserted-by":"crossref","first-page":"994","DOI":"10.3390\/ani15070994","article-title":"Plasma lipidomics and proteomics analyses pre- and post-5000 m race in Yili horses","volume":"15","author":"Wang","year":"2025","journal-title":"Animals"},{"key":"10.1016\/j.chroma.2026.467244_bib0038","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0173615","article-title":"The human plasma-metabolome: reference values in 800 French healthy volunteers; impact of cholesterol, gender and age","volume":"12","author":"Trabado","year":"2017","journal-title":"PLOS ONE"},{"key":"10.1016\/j.chroma.2026.467244_bib0039","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124844","article-title":"Metabolomic fingerprint of heart failure with preserved ejection fraction","volume":"10","author":"Zordoky","year":"2015","journal-title":"PLOS ONE"},{"key":"10.1016\/j.chroma.2026.467244_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113945","article-title":"Impact of ionizable lipid type on the pharmacokinetics and biodistribution of mRNA-lipid nanoparticles after intravenous and subcutaneous injection","volume":"384","author":"Ren","year":"2025","journal-title":"J. Control. Rel."},{"key":"10.1016\/j.chroma.2026.467244_bib0041","doi-asserted-by":"crossref","first-page":"27077","DOI":"10.1021\/acsnano.4c11652","article-title":"Blood distribution of SARS-CoV-2 lipid nanoparticle mRNA vaccine in humans","volume":"18","author":"Kent","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.chroma.2026.467244_bib0042","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1021\/mp400584h","article-title":"Quantitation of physiological and biochemical barriers to siRNA liver delivery via lipid nanoparticle platform","volume":"11","author":"Xu","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.chroma.2026.467244_bib0043","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1038\/mt.2013.124","article-title":"Biodegradable lipids enabling rapidly eliminated lipid nanoparticles for systemic delivery of RNAi therapeutics","volume":"21","author":"Maier","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.chroma.2026.467244_bib0044","doi-asserted-by":"crossref","first-page":"8699","DOI":"10.1038\/s41467-025-63726-2","article-title":"Protein corona formed on lipid nanoparticles compromises delivery efficiency of mRNA cargo","volume":"16","author":"Voke","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.chroma.2026.467244_bib0045","doi-asserted-by":"crossref","first-page":"503","DOI":"10.2217\/nnm.14.184","article-title":"No king without a crown - impact of the nanomaterial-protein corona on nanobiomedicine","volume":"10","author":"Docter","year":"2015","journal-title":"Nanomed"},{"key":"10.1016\/j.chroma.2026.467244_bib0046","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jchromb.2019.06.016","article-title":"Characterization of supported liquid extraction as a sample pretreatment method for eicosanoids and related metabolites in biological fluids","volume":"1124","author":"Kohira","year":"2019","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.chroma.2026.467244_bib0047","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2021.122672","article-title":"Optimization and application of high-throughput supported liquid extraction for simultaneous determination of carotenoids and fat-soluble vitamins in serum","volume":"1173","author":"Qi","year":"2021","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.chroma.2026.467244_bib0048","unstructured":"Biotage, Extraction of fat-soluble vitamins from human serum using ISOLUTE\u00ae SLE+. https:\/\/www.biotage.com\/literature\/application-note\/extraction-fat-soluble-vitamins-human-serum-isolute-sle (accessed December 13, 2025)."},{"key":"10.1016\/j.chroma.2026.467244_bib0049","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/bmc.3686","article-title":"The impact of phospholipids and phospholipid removal on bioanalytical method performance","volume":"30","author":"Carmical","year":"2016","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.chroma.2026.467244_bib0050","doi-asserted-by":"crossref","DOI":"10.1038\/srep38885","article-title":"Systematic assessment of seven solvent and solid-phase extraction methods for metabolomics analysis of human plasma by LC-MS","volume":"6","author":"Sitnikov","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.chroma.2026.467244_bib0051","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1007\/s00216-012-6039-y","article-title":"Current trends and challenges in sample preparation for global metabolomics using liquid chromatography-mass spectrometry","volume":"403","author":"Vuckovic","year":"2012","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.chroma.2026.467244_bib0052","unstructured":"Association of Official Racing Chemists (AORC), AORC guidelines for the minimum criteria for identification by chromatography and mass spectrometry. https:\/\/www.aorc-online.org\/documents\/aorc-ms-criteria-ilacg7\/1aorc-ms-criteria-mar-24.pdf (accessed June 19, 2026)."},{"key":"10.1016\/j.chroma.2026.467244_bib0053","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1093\/clinchem\/48.10.1647","article-title":"Stability of endogenous and added RNA in blood specimens, serum, and plasma","volume":"48","author":"Tsui","year":"2002","journal-title":"Clin. Chem."},{"key":"10.1016\/j.chroma.2026.467244_bib0054","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.3390\/genes12121874","article-title":"Transcriptomic markers of recombinant human erythropoietin micro-dosing in thoroughbred horses","volume":"12","author":"Dahlgren","year":"2021","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.chroma.2026.467244_bib0055","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.2042-3306.1997.tb03132.x","article-title":"Nonregenerative anaemia associated with administration of recombinant human erythropoietin to a thoroughbred racehorse","volume":"29","author":"Woods","year":"1997","journal-title":"Equine Vet. J."},{"key":"10.1016\/j.chroma.2026.467244_bib0056","doi-asserted-by":"crossref","first-page":"244","DOI":"10.2460\/javma.1998.212.02.244","article-title":"Erythroid hypoplasia and anemia following administration of recombinant human erythropoietin to two horses","volume":"212","author":"Piercy","year":"1998","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"10.1016\/j.chroma.2026.467244_bib0057","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.2042-3306.2006.tb05545.x","article-title":"Low dose exogenous erythropoietin elicits an ergogenic effect in Standardbred horses","volume":"38","author":"McKEEVER","year":"2006","journal-title":"Equine Vet. J."},{"key":"10.1016\/j.chroma.2026.467244_bib0058","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.resp.2016.02.001","article-title":"Effects of erythropoietin on systemic hematocrit and oxygen transport in the splenectomized horse","volume":"225","author":"McKeever","year":"2016","journal-title":"Respir. Physiol. Neurobiol."},{"key":"10.1016\/j.chroma.2026.467244_bib0059","unstructured":"F\u00e9d\u00e9ration \u00c9questre Internationale (FEI), FEI tribunal issues final decision on two banned substance cases. https:\/\/inside.fei.org\/media-updates\/fei-tribunal-issues-final-decision-two-banned-substance-cases (accessed June 22, 2026)."},{"key":"10.1016\/j.chroma.2026.467244_bib0060","doi-asserted-by":"crossref","first-page":"4749","DOI":"10.1021\/ac071928d","article-title":"Chasing down drugged racehorses","volume":"79","author":"Mukhopadhyay","year":"2007","journal-title":"Anal. Chem."},{"key":"10.1016\/j.chroma.2026.467244_bib0061","unstructured":"International Federation of Horseracing Authorities (IFHA), The international agreement on breeding, racing and wagering and appendixes. https:\/\/www.ifhaonline.org\/default.asp?section=IABRW&area=15 (accessed May 15, 2026)."}],"container-title":["Journal of Chromatography A"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002196732600573X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002196732600573X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T20:29:29Z","timestamp":1787603369000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002196732600573X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":61,"alternative-id":["S002196732600573X"],"URL":"https:\/\/doi.org\/10.1016\/j.chroma.2026.467244","relation":{},"ISSN":["0021-9673"],"issn-type":[{"value":"0021-9673","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Detection of ionisable lipids in equine plasma by supported liquid extraction and liquid chromatography-high-resolution tandem mass spectrometry for doping control of mRNA agents","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography A","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chroma.2026.467244","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"467244"}}